Q9Y468 (LMBL1_HUMAN) Homo sapiens (Human)

Lethal(3)malignant brain tumor-like protein 1 UniProtKBInterProSTRINGInteractive Modelling

840 aa; Sequence (Fasta) ; (Isoform 1; Isoform 2; Isoform 3; Isoform 4; )

Sequence Features

Add
 423Mediates recognition of monomethylated and dimethylated peptides
 426Positioned at the entrance of MBT 2 and is required for recognition of monomethylated and dimethylated peptides
 117S -> T (in dbSNP:rs17857202) VAR_051097 dbSNP
 547I -> M (in dbSNP:rs6017104) VAR_051098 dbSNP
 613-656CCHHC-type
 310-378Mbt repeat
IPR004092PF02820
 417-484Mbt repeat
IPR004092PF02820
 521-587Mbt repeat
IPR004092PF02820
 621-649Zinc finger, C2H2C-type
IPR002515PF01530

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRange
Crystal structure of the 3-MBT domain from human L3MBTL1 in complex with H1.5K27me2 at 1.66 angstrom Heteromer
P16401;
PG4;PEG;2rhi273-594
Assess
Crystal structure of L3MBTL1 in complex with H4K20Me2 (residues 17-25), orthorhombic form II Heteromer
P62805;
CL;2rje274-586
Assess
Crystal structure of the 3-MBT domain from human L3MBTL1 in complex with p53K382me1 Heteromer
P04637;
3oq5274-586
Assess
CRYSTAL STRUCTURE OF 3-MBT REPEATS OF LETHAL (3) MALIGNANT BRAIN TUMOR (SELENO-MET) AT 1.85 ANGSTROMhomo-9-mer 42×SO4; 21×MES;1oyx274-586
Assess
Crystal Structure of 3-MBT repeats of lethal (3) malignant Brain Tumor (Native-I) at 1.85 angstromhomo-9-mer 30×SO4; 18×MES;1oz3274-586
Assess
Crystal structure of L3MBTL1 in complex with H4K20Me2 (residues 12-30), orthorhombic form Ihomo-2-mer 2rjf274-588
Assess
Crystal structure of L3MBTL1 proteinmonomer 2rjd272-596
Assess
Crystal structure of the 3-MBT repeats from human L3MBTL1 bound to dimethyl-lysine and in chimera w…monomer SO4;MLY;PG4;PEG;2rhu274-598
Assess
CRYSTAL STRUCTURE OF 3-MBT REPEATS OF LETHAL (3) MALIGNANT BRAIN TUMOR (NATIVE-II) AT 1.55 ANGSTROMmonomer SO4;MES;1oz2272-595
Assess
The 3-MBT repeat domain of L3MBTL1 in complex with a methyl-lysine mimicmonomer UWN; 14×UNX;3uwn272-595
Assess
Crystal structure of the 3-MBT repeats from human L3MBTL1 bound to dimethyl-lysinemonomer SO4;MLY;PG4;PGE;2rhx272-594
Assess
Crystal structure of L3MBTL1 MBT Domain with MBK14970monomer EC7;EDO; 13×UNX;6byb272-588
Assess
Crystal structure of L3MBTL1 in complex with H4K20Me2 (residues 17-25), trigonal formmonomer ACT;2pqw274-588
Assess
Crystal structure of the 3-MBT repeats from human L3MBTL1 bound to monomethyl-lysinemonomer MLZ;PEG;2rhy274-587
Assess
Crystal structure of the 3-MBT repeats from human L3MBTL1 with N358A point mutationmonomer PGE;PEG;2ri5274-587
Assess
Crystal structure of the 3-MBT repeats from human L3MBTL1 with N358Q point mutationmonomer PEG;2ri3274-587
Assess
Crystal structure of the 3-MBT repeats from human L3MBTL1 with D355N point mutationmonomer PEG;2rhz274-587
Assess
Crystal structure of the 3-MBT repeats from human L3MBTL1 with D355A point mutationmonomer SO4;PGE;PEG;2ri2274-587
Assess
Crystal structure of L3MBTL1 protein in complex with MESmonomer SO4;MES;2rjc274-586
Assess
Crystal structure of L3MBTL1 (MBT repeat) in complex with a nicotinamide antagonistmonomer P8H;SO4;GOL;3p8h274-586
Assess

Homology models

Oligo-stateQMEANTemplateRangeSeq id (%)Ligands
monomer -4.97 1pxe.1.A618-657
52.50
Assess
monomer -1.85 4pzn.1.A746-793
31.71
Assess

Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANTemplateRangeSeq id (%)
Isoform 1monomer0.902rjd.1.A204-528
100.00
Assess
Isoform 1monomer-5.121pxe.1.A550-588
53.85
Assess
Isoform 1monomer-1.834pzn.1.A678-725
31.71
Assess
Isoform 2monomer0.912rjd.1.A204-528
100.00
Assess
Isoform 2monomer-5.041pxe.1.A550-589
52.50
Assess
Isoform 3monomer1.412rjd.1.A1-180
100.00
Assess
Isoform 3monomer-4.621pxe.1.A203-240
55.26
Assess
Isoform 4monomer0.902rjd.1.A204-528
100.00
Assess
Isoform 4monomer-1.554pzn.1.A678-747
40.00
Assess